Find a Researcher
Tomoki Hashimoto, MD
Neuro-anesthesiology and Neurobiology
Tomoki Hashimoto, MD, is a professor of neuro-anesthesiology and neurobiology and the director of translational neurovascular research in the Barrow Aneurysm and AVM Research Center. He is board certified in anesthesiology by the American Board of Anesthesiology.
Dr. Hashimoto’s expertise includes clinical anesthesiology and vascular biology. He earned his medical degree from Gifu University School of Medicine in Japan. He received his residency training in anesthesia at Gifu University Hospital, Thomas Jefferson University Hospital in Philadelphia, and NewYork-Presbyterian/Columbia University Medical Center. He completed a clinical fellowship at NewYork-Presbyterian/Columbia Medical Center and a research fellowship at the University of California-San Francisco, both in neuro-anesthesia.
Dr. Hashimoto leads a program that focuses on the translational research of cerebrovascular diseases. His group studies the roles of inflammation and vascular remodeling in the pathophysiology of intracranial aneurysms and brain arteriovenous malformations. They are developing pharmacological therapies for the prevention of stroke caused by rupture of intracranial aneurysms and brain arteriovenous malformations.
- Research Fellow, University of California-San Francisco, Neuro-anesthesia, 2000-2001
- Fellow, NewYork-Presbyterian/Columbia Medical Center, Neuro-anesthesia, 1999-2000
- Resident, NewYork-Presbyterian/Columbia Medical Center, Anesthesia, 1997-1999
- Resident, Thomas Jefferson University Hospital, Anesthesia, 1996-1997
- Internship, Chestnut Hill Hospital, 1995-1996
- Resident, Gifu University Hospital, Anesthesia, 1992-1995
- MD, Gifu University, School of Medicine, 1992
- American Heart Association
- American Society of Anesthesiologists
- Association of University Anesthesiologists
- Fellow of the American Heart Association, 2013
- Pfizer Health Care Research Scholarship, 1997
- Noguchi Medical Research Institute Scholarship for U.S.A. Visiting Program, 1994
- Noguchi Medical Research Institute Scholarship for U.S.A. Short Visiting Program, 1993
Mitochondrial fission inhibition protects against hypertension induced by angiotensin II.
Date: 05/2024
Authors: Kyle J Preston, Tatsuo Kawai, Keiichi Torimoto, Ryohei Kuroda, Yuki Nakayama, Tomoko Akiyama, Yayoi Kimura, Rosario Scalia, Michael V Autieri, Victor Rizzo, Tomoki Hashimoto, Patrick Osei-Owusu, Satoru Eguchi
Pharmacological Inhibition of Epidermal Growth Factor Receptor Prevents Intracranial Aneurysm Rupture by Reducing Endoplasmic Reticulum Stress.
Date: 03/2024
Authors: Taichi Ishiguro, Hajime Furukawa, Kyle Polen, Yushiro Take, Hiroki Sato, Daisuke Kudo, Jordan Morgan, Hiroki Uchikawa, Takuma Maeda, Oscar Cisneros, Redi Rahmani, Jinglu Ai, Satoru Eguchi, Michael T Lawton, Tomoki Hashimoto
Current Mouse Models of Intracranial Aneurysms: Analysis of Pharmacological Agents Used to Induce Aneurysms and Their Impact on Translational Research.
Date: 02/2024
Authors: Dilaware Khan, Xuanchen Li, Tomoki Hashimoto, Rokuya Tanikawa, Mika Niemela, Michael Lawton, Sajjad Muhammad
Vitamin D deficiency promotes intracranial aneurysm rupture.
Date: 01/2024
Authors: Tetsuro Kimura, Redi Rahmani, Takeshi Miyamoto, Yoshinobu Kamio, Daisuke Kudo, Hiroki Sato, Taichi Ikedo, Jacob F Baranoski, Hiroki Uchikawa, Jinglu Ai, Michael T Lawton, Tomoki Hashimoto
Angiotensin II Type 1A Receptor Expressed in Smooth Muscle Cells is Required for Hypertensive Vascular Remodeling in Mice Infused With Angiotensin II
Date: 03/2023
Authors: Keisuke Okuno, Keiichi Torimoto, Stephanie M. Cicalese, Kyle Preston, Victor Rizzo, Tomoki Hashimoto, Nobuo Hashimoto, Thomas M. Coffman, Matthew A. Sparks, Satoru Eguchi
Tomoki Hashimoto, MD
Neuro-anesthesiology and Neurobiology
Tomoki Hashimoto, MD, is a professor of neuro-anesthesiology and neurobiology and the director of translational neurovascular research in the Barrow Aneurysm and AVM Research Center. He is board certified in anesthesiology by the American Board of Anesthesiology.
Dr. Hashimoto’s expertise includes clinical anesthesiology and vascular biology. He earned his medical degree from Gifu University School of Medicine in Japan. He received his residency training in anesthesia at Gifu University Hospital, Thomas Jefferson University Hospital in Philadelphia, and NewYork-Presbyterian/Columbia University Medical Center. He completed a clinical fellowship at NewYork-Presbyterian/Columbia Medical Center and a research fellowship at the University of California-San Francisco, both in neuro-anesthesia.
Dr. Hashimoto leads a program that focuses on the translational research of cerebrovascular diseases. His group studies the roles of inflammation and vascular remodeling in the pathophysiology of intracranial aneurysms and brain arteriovenous malformations. They are developing pharmacological therapies for the prevention of stroke caused by rupture of intracranial aneurysms and brain arteriovenous malformations.
- Research Fellow, University of California-San Francisco, Neuro-anesthesia, 2000-2001
- Fellow, NewYork-Presbyterian/Columbia Medical Center, Neuro-anesthesia, 1999-2000
- Resident, NewYork-Presbyterian/Columbia Medical Center, Anesthesia, 1997-1999
- Resident, Thomas Jefferson University Hospital, Anesthesia, 1996-1997
- Internship, Chestnut Hill Hospital, 1995-1996
- Resident, Gifu University Hospital, Anesthesia, 1992-1995
- MD, Gifu University, School of Medicine, 1992
- American Heart Association
- American Society of Anesthesiologists
- Association of University Anesthesiologists
- Fellow of the American Heart Association, 2013
- Pfizer Health Care Research Scholarship, 1997
- Noguchi Medical Research Institute Scholarship for U.S.A. Visiting Program, 1994
- Noguchi Medical Research Institute Scholarship for U.S.A. Short Visiting Program, 1993
Mitochondrial fission inhibition protects against hypertension induced by angiotensin II.
Date: 05/2024
Authors: Kyle J Preston, Tatsuo Kawai, Keiichi Torimoto, Ryohei Kuroda, Yuki Nakayama, Tomoko Akiyama, Yayoi Kimura, Rosario Scalia, Michael V Autieri, Victor Rizzo, Tomoki Hashimoto, Patrick Osei-Owusu, Satoru Eguchi
Pharmacological Inhibition of Epidermal Growth Factor Receptor Prevents Intracranial Aneurysm Rupture by Reducing Endoplasmic Reticulum Stress.
Date: 03/2024
Authors: Taichi Ishiguro, Hajime Furukawa, Kyle Polen, Yushiro Take, Hiroki Sato, Daisuke Kudo, Jordan Morgan, Hiroki Uchikawa, Takuma Maeda, Oscar Cisneros, Redi Rahmani, Jinglu Ai, Satoru Eguchi, Michael T Lawton, Tomoki Hashimoto
Current Mouse Models of Intracranial Aneurysms: Analysis of Pharmacological Agents Used to Induce Aneurysms and Their Impact on Translational Research.
Date: 02/2024
Authors: Dilaware Khan, Xuanchen Li, Tomoki Hashimoto, Rokuya Tanikawa, Mika Niemela, Michael Lawton, Sajjad Muhammad
Vitamin D deficiency promotes intracranial aneurysm rupture.
Date: 01/2024
Authors: Tetsuro Kimura, Redi Rahmani, Takeshi Miyamoto, Yoshinobu Kamio, Daisuke Kudo, Hiroki Sato, Taichi Ikedo, Jacob F Baranoski, Hiroki Uchikawa, Jinglu Ai, Michael T Lawton, Tomoki Hashimoto
Angiotensin II Type 1A Receptor Expressed in Smooth Muscle Cells is Required for Hypertensive Vascular Remodeling in Mice Infused With Angiotensin II
Date: 03/2023
Authors: Keisuke Okuno, Keiichi Torimoto, Stephanie M. Cicalese, Kyle Preston, Victor Rizzo, Tomoki Hashimoto, Nobuo Hashimoto, Thomas M. Coffman, Matthew A. Sparks, Satoru Eguchi